8 November 2018
\n \n \n \nOCMR study uses advanced MRI to find those most at risk
\n \n\n \n \n8 November 2018
\n \n \n \n\n \n \n23 October 2018
\n \n \n \nIn the late 1960s Miles Vaughan Williams, a member of the staff in the Oxford Department of Pharmacology and Fellow of Hertford College (1955-85), introduced a novel classification of drugs used to treat cardiac arrhythmias. This scheme has been very widely used around the world and has led to the development of new drugs that have saved countless lives. Our understanding of the control of cardiac rhythm has developed in that time and a group of cardiovascular scientists from Oxford, Cambridge and Beijing led by Associate Professor Ming Lei decided that the time was ripe to modernise the classification and to celebrate the centenary of the birth of Vaughan Williams.
\n \n\n \n \n19 October 2018
\n \n \n \nResearch fostered at RDM has increased the accuracy of echocardiogram interpretations, pinpointing many more people at risk of heart disease.
\n \n\n \n \n10 October 2018
\n \n \n \nCaristo Diagnostics, an Oxford University spinout company, has been launched to commercialise a new coronary CT image analysis technology that can flag patients at risk of deadly heart attacks years before they occur.
\n \n\n \n \n26 September 2018
\n \n \n \nOxford University is rated world\u2019s number one for the third straight year in the Times Higher Education world university rankings. Oxford, the only UK University ever to top the international rankings, keeps first spot through the outstanding quality of its research, teaching and innovation.
\n \n\n \n \n28 August 2018
\n \n \n \nResearchers at the University of Oxford, working with colleagues in Erlangen, Germany and at the Cleveland Clinic, USA, have developed a new technology based on analysis of computed tomography (CT) coronary angiograms that can flag patients at risk of deadly heart attacks years before they occur.
\n \n\n \n \n28 August 2018
\n \n \n \nFish oil supplements do not prevent heart attacks or strokes in patients with diabetes, according to late breaking results from the ASCEND trial presented today in a Hot Line Session at ESC Congress 2018 and published in the New England Journal of Medicine.
\n \n\n \n \n28 August 2018
\n \n \n \nDrugs currently in Phase III clinical trials could be repurposed to help people with diabetes recover after a heart attack
\n \n\n \n \n31 May 2018
\n \n \n \n\n \n \n25 April 2018
\n \n \n \nCongratulations to Prof Shoumo Bhattacharya who has secured a \u00a31m programme grant from the British Heart Foundation to further his research on the use of novel anti-inflammatories in cardiovascular disease.
\n \n\n \n \n3 April 2018
\n \n \n \nCongratulations to Dr Adam Lewandowski, who has secured a five-year British Heart Foundation Intermediate Basic Science Fellowship to study the impact of premature birth on the heart.
\n \n\n \n \n1 April 2018
\n \n \n \n\n \n \n20 March 2018
\n \n \n \n\n \n \n19 March 2018
\n \n \n \nThe hearts of people born prematurely are less able to cope with the pressures of exercise in adulthood, according to a new study published in the Journal of the American College of Cardiology and part-funded by the British Heart Foundation and the NIHR Oxford Biomedical Research Centre.
\n \n\n \n \n12 March 2018
\n \n \n \n\n \n \n12 February 2018
\n \n \n \n\n \n \n8 February 2018
\n \n \n \n\n \n \n24 January 2018
\n \n \n \n\n \n \n5 January 2018
\n \n \n \nResearchers from the University of Oxford are using artificial intelligence to improve diagnostic accuracy for heart disease. The team hope to roll out the system across the NHS later this year, helping to improve patient outcomes and saving millions is misdiagnoses. The research, led by Prof Paul Leeson and RDM DPhil student Ross Upton (Cardiovascular Clinical Research Facility), took place in the Oxford University Hospitals Foundation Trust and is the basis of spin-out company Ultromics.
\n \n\n \n \n